Follow the people · Insider
Shelia M. Violette
Shelia M. Violette files insider transactions with the SEC as a chief scientific officer of Q32 Bio (QTTB). We hold 2 disclosed purchases and sales filed since 27 March 2024, 1 of them in the last 90 days.
- Files forQTTB
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure27 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 March 2024 — 25 August 2026Chief Scientific Officer · Q32 Bio (QTTB)24 Form 4 lines · source: SEC Form 4
Everything they disclosed
24 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,798 shares of Q32 BioSEC Form 427 August 2026Common Stock · traded 25 August 2026 · filed 27 August 2026
- was granted 37,500 shares of Q32 BioSEC Form 420 July 2026Common Stock · traded 16 July 2026 · filed 20 July 2026
- was granted 37,500 shares of Q32 BioSEC Form 420 March 2026Common Stock · traded 24 February 2026 · filed 20 March 2026
- was granted 37,500 shares of Q32 BioSEC Form 420 March 2026Common Stock · traded 24 February 2026 · filed 20 March 2026
- ▼ sold on the open market 2,815 shares of Q32 BioSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 2,815 shares of Q32 BioSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 2,990 shares of Q32 BioSEC Form 428 August 2025Common Stock · traded 26 August 2025 · filed 28 August 2025
- returned to the issuer 32,891 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- was granted 32,891 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- returned to the issuer 13,305 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- was granted 13,305 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- returned to the issuer 17,506 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- was granted 17,506 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- returned to the issuer 56,413 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- was granted 56,413 shares of Q32 Bio (a derivative holding)SEC Form 426 February 2025Stock Option (Right to Buy) · traded 24 February 2025 · filed 26 February 2025
- was granted 37,500 shares of Q32 BioSEC Form 426 February 2025Common Stock · traded 24 February 2025 · filed 26 February 2025
- exercised options over 213 shares of Q32 Bio (a derivative holding)SEC Form 416 October 2024Stock Option (Right to Buy) · traded 11 October 2024 · filed 16 October 2024
- exercised options over 4,361 shares of Q32 Bio (a derivative holding)SEC Form 416 October 2024Stock Option (Right to Buy) · traded 11 October 2024 · filed 16 October 2024
- exercised options over 6,000 shares of Q32 Bio (a derivative holding)SEC Form 416 October 2024Stock Option (Right to Buy) · traded 15 October 2024 · filed 16 October 2024
- exercised options over 4,574 shares of Q32 BioSEC Form 416 October 2024Common Stock · traded 11 October 2024 · filed 16 October 2024
- exercised options over 6,000 shares of Q32 BioSEC Form 416 October 2024Common Stock · traded 15 October 2024 · filed 16 October 2024
- exercised options over 13,300 shares of Q32 Bio (a derivative holding)SEC Form 410 October 2024Stock Option (Right to Buy) · traded 8 October 2024 · filed 10 October 2024
- exercised options over 13,300 shares of Q32 BioSEC Form 410 October 2024Common Stock · traded 8 October 2024 · filed 10 October 2024
- was granted 56,413 shares of Q32 Bio (a derivative holding)SEC Form 427 March 2024Stock Option (Right to Buy) · traded 25 March 2024 · filed 27 March 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.